| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | 0.031 | 0.8 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.0068 | 0.8 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |